Sponsors

Lead Sponsor

Boston Scientific Corporation

The PEARL II Registry is a prospective, multi-center, observational registry including 500 patients who meet eligibility from up to 50 sites worldwide. Patient participation will be 12 months including post procedure follow-up contact at 3, 6 and 12 months. The study duration is estimated at 36 months. A patient's treatment is determined by the treating physician based on the clinical situation and local practices. In contrast to a randomized, controlled trial, there are no pre-defined experimental interventions.

Related studies

RECRUITINGPhase 3

A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE)

NCT06656988 · Peripheral Vascular Diseases, Kidney Diseases

RECRUITING

Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

NCT07372170 · Antiphospholipid Syndrome (APS), Venous Thrombosis (Disorder), and more

RECRUITING

Registry of AngioJet Use in the Peripheral Vascular System

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

A Contrast Medium Sparing Strategy Using Automated CO2 Injection During PVI for Prevention of Major Adverse Kidney Events (MAKE)

Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Registry of Catheter Intervention in Pulmonary Embolism

Trial snapshot

Condition

Locations shown

For caregivers